YS Biopharma Co., Ltd. reported earnings results for the nine months ended December 31, 2023. For the nine months, the company reported sales was CNY 0.438069 million compared to CNY 0.581184 million a year ago. Net loss was CNY 0.252293 million compared to CNY 0.172506 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.715 USD | +3.61% | -0.83% | +39.92% |
Jun. 10 | Lakeshore Biopharma Co., Ltd Announces Executive Changes | CI |
May. 28 | YS Biopharma Co., Ltd. will Change its Ticker to LSB from YS | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.92% | 135M | |
+2.44% | 94.37B | |
-0.66% | 38.14B | |
-13.57% | 32.56B | |
+76.24% | 28.24B | |
-12.73% | 15.98B | |
-2.15% | 13.82B | |
-13.59% | 11.57B | |
+158.88% | 10.52B | |
-52.04% | 9.89B |
- Stock Market
- Equities
- LSB Stock
- News LakeShore Biopharma Co., Ltd
- YS Biopharma Co., Ltd. Reports Earnings Results for the Nine Months Ended December 31, 2023